Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects
MarkTechPost ·
Summary
Google DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research. The post Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specifi
- Source
- MarkTechPost
- Published (IST)
Original reporting belongs to MarkTechPost. DEEKOYA links the headline and a short excerpt only; we do not republish the full article.
Explore more: Today in AI · Research papers · AI tools · Learn AI
Related stories
- U.S. News & World Report
Patients More Comfortable Than Doctors With AI-Driven Healthcare Decisions, Survey Finds
U.S. News & World ReportAI
- cbs19.tv
Microsoft outage disrupts Outlook, Teams and Copilot users worldwide
cbs19.tvAI
Wired AI
This Startup Is Betting on AI Microdramas to Get More Black Stories in Hollywood
Mansa says its AI microdramas can serve as proofs of concept for what Black audiences want. Critics say the studio is…
Wired AIBusiness
BBC Technology
What we know so far about the Microsoft outage
A Microsoft outage is affecting services including Teams, Outlook and AI software Copilot.
BBC TechnologyAI
Unite.AI
Translated Releases Lara Mini, a 45-Language Research Model
Translated announced Lara Mini on November 12, 2026, releasing a research model trained from scratch on 6 trillion…
Unite.AIPolicy
- Audacy
JPMorgan sees U.S. humanoid robot output reaching 400,000 by 2030
AudacyAI
Who reported “Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects”?
MarkTechPost, on 12 Nov 2026. The full article is at the source link on this page.
Comments
No comments yet. Share your own experience below.
Visitor posts are moderated before they appear and are the opinion of their authors, not DEEKOYA AI. Names are not verified. See our privacy policy.